UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number: 000-51323
 
Micrus Endovascular Corporation  
(Exact name of registrant as specified in its charter)
 
821 Fox Lane
San Jose, California 95131, (408) 433-1400
 
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)
 
Common Stock, par value $0.01 per share  
 
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
   Rule 12g-4(a)(1) x  
    Rule 12g-4(a)(2) o  
   Rule 12h-3(b)(1)(i) x  
    Rule 12h-3(b)(1)(ii) o  
    Rule  15d-6 o  
 
Approximate number of holders of record as of the certification or notice date: 1
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Micrus Endovascular Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date:  September 27, 2010
MICRUS ENDOVASCULAR CORPORATION  
       
 
By:
/s/ Clifford Birge  
    Clifford Birge  
    Secretary  
       
 
 
 
Micrus Endovascular (MM) (NASDAQ:MEND)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Micrus Endovascular (MM) Charts.
Micrus Endovascular (MM) (NASDAQ:MEND)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Micrus Endovascular (MM) Charts.